Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. IXJ: which is better?

Bottom line

XLV vs IXJ: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 76% by weight.

XLV is cheaper at 0.08% vs 0.38% — a difference of $30 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +6.4% for IXJ.

Updated Nov 19, 2026

XLV vs IXJ side by side

XLVIXJ
TypeETFETF
Fund familySPDR (State Street)iShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.38%
Annual cost per $10k$8$38
10-yr cost on $10k (prospectus)$103$480
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+14.9%
5-yr return (annualized)+8.1%+6.4%
10-yr return (annualized)+9.8%+8.2%
Best quarter+14.5%+13.6%
Worst quarter−12.7%−11.8%
Net assets (fund)$40.6B$3.8B
Number of holdings65124
Portfolio turnover2%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVIXJDifference
2025+14.5%+14.9%−0.3%
2024+2.5%+0.6%+1.9%
2023+2.0%+3.5%−1.5%
2022−2.1%−4.7%+2.6%
2021+25.9%+19.5%+6.4%
2020+13.3%+12.5%+0.8%
2019+20.7%+23.4%−2.7%
2018+6.3%+2.9%+3.4%
2017+21.7%+20.3%+1.4%
2016−2.8%−6.2%+3.4%

Source: Fund prospectus bar charts

Holdings overlap

18 of XLV's top 25 holdings also appear in IXJ's top 25.

Shared top holdings
HoldingXLVIXJ
Eli Lilly & Co16.51%10.93%
Johnson & Johnson10.64%7.04%
AbbVie Inc7.74%5.12%
UnitedHealth Group Inc6.57%4.40%
Merck & Co Inc5.52%4.12%
Amgen Inc3.40%2.54%
Thermo Fisher Scientific Inc3.24%2.42%
Abbott Laboratories2.75%2.05%
Gilead Sciences Inc2.73%2.04%
Intuitive Surgical Inc2.45%1.83%
Pfizer Inc2.39%1.78%
CVS Health Corp2.30%1.71%
Vertex Pharmaceuticals Inc2.19%1.64%
Danaher Corp2.09%1.56%
Bristol-Myers Squibb Co2.05%1.53%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

FAQ

What is the difference between XLV and IXJ?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 76% by weight. XLV is cheaper at 0.08% vs 0.38% — a difference of $30 a year per $10,000 invested.
Which is cheaper, XLV or IXJ?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and IXJ?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.